Author Policies
- Plagiarism Policy
- Copyright Policy
- Article Processing Charge
- Author’s Agreement Form
- English Language Editing
- Withdrawal Policy
- Human and Animal Rights Policy
- Errata, Retractions, and Corrigenda Policy
- Digital Preservation
- APC Waiver Policy
- Participant/Patient Privacy and Informed Consent
- Submission of Manuscript
- Manuscript Preparation
- Check List
- Rights and Grants to the Author
- Licensing Policy
- Data Sharing Policy
- Sample Paper
- Complaints Policy
- Open Access Policy
1. Plagiarism Policy
The Indo-American Journal of Pharma and Bio Sciences maintains a stringent plagiarism policy to uphold academic integrity and maintain the quality of published research. The journal requires that all submissions be original works, free from any form of plagiarism. Any manuscript that contains plagiarized content—whether it is text, data, or ideas—will be immediately rejected, and the author may be barred from submitting future works to the journal. The editorial board uses advanced plagiarism detection tools to screen all submissions for similarities with previously published works. Authors must also properly cite and reference any sources they have consulted during their research, including datasets, articles, and other academic materials. If plagiarism is detected after an article has been published, the journal will follow strict procedures to address the issue, which may include retracting the paper or issuing a corrigendum. Authors are encouraged to thoroughly check their manuscripts before submission to ensure that all references are accurate and that proper citations are included for any work that influenced their study. In cases where plagiarism is not intentional, the editorial team may provide guidance to the authors on best practices for citation. This policy ensures that the Indo-American Journal of Pharma and Bio Sciences remains a reliable and trustworthy source of scientific knowledge, promoting academic excellence and ethical publishing practices.
2.Copyright Policy
The Indo-American Journal of Pharma and Bio Sciences adheres to a copyright policy that aims to protect both the rights of authors and the integrity of the published work. Authors who submit their manuscripts to the journal retain the copyright to their intellectual property but grant the journal an exclusive license to publish the article. This means that authors can reuse their work in other contexts, such as in books, presentations, or other research papers, provided they cite the journal where the article was originally published. The journal typically publishes articles under a Creative Commons Attribution (CC BY) license, which allows others to share, reuse, and adapt the work, as long as proper attribution is given to the original authors. This open licensing model promotes wider dissemination of research findings and encourages collaborative and transformative uses of the content. While authors retain their copyright, the exclusive license granted to the journal ensures that the article can be distributed globally and freely through the open-access platform. Authors are also encouraged to upload their work to institutional or subject-based repositories, with proper citation, to maximize its visibility. The Indo-American Journal of Pharma and Bio Sciences aims to foster a publishing environment where authors have control over their work while ensuring the broadest possible access to research findings in the fields of pharmaceuticals and biosciences.
3. Article Processing Charge (APC)
To maintain high editorial and publishing standards, the Indo-American Journal of Pharma and Bio Sciences charges an Article Processing Charge (APC) for accepted articles. This fee helps cover the costs associated with manuscript peer review, editorial processing, typesetting, and the dissemination of articles in an open-access format. The APC ensures that the journal can remain fully open access, allowing free access to all readers without paywalls or subscription fees. The journal is transparent about the APC structure, and authors will be informed of the applicable fees upon acceptance of their manuscripts. The APC varies depending on the complexity and length of the article, as well as the availability of funding from the authors' institutions or funding agencies. The journal strives to ensure that this charge does not act as a barrier to publication, particularly for authors from low- and middle-income countries. For such authors, the Indo-American Journal of Pharma and Bio Sciences provides a waiver or reduction in the APC, upon request, based on financial need or institutional support. In cases where funding is available from grants, authors should disclose this information when submitting the manuscript. The APC model ensures sustainability and supports the journal's mission to provide open-access, high-quality research across the pharmaceutical and biosciences disciplines. Authors should confirm their willingness and ability to pay the APC prior to manuscript submission.
4. Author’s Agreement Form
The Indo-American Journal of Pharma and Bio Sciences requires authors to sign an Author’s Agreement Form at the time of manuscript submission. This form is a legally binding agreement that outlines the responsibilities and rights of the author(s) and the journal. By signing the form, the author confirms that the manuscript is original, not under consideration elsewhere, and free from plagiarism. The author also asserts that all co-authors have contributed to the work and agreed to its submission to the journal. The agreement specifies that the author grants the journal the exclusive right to publish the manuscript and distributes it under a Creative Commons license. The author retains the copyright but agrees to allow the journal to publish and distribute the article globally. Additionally, the form requires the author to disclose any conflicts of interest, including financial, personal, or professional ties that may influence the manuscript. If applicable, the author must provide evidence of ethical approval for research involving human or animal subjects. The form also acknowledges that the article may be subject to revisions after peer review and that the journal has the right to reject or accept the manuscript based on the review process. The Author's Agreement Form ensures clarity in the publishing process and protects both the author’s rights and the journal’s editorial responsibilities.
5. English Language Editing
The Indo-American Journal of Pharma and Bio Sciences recognizes the importance of clear, professional, and grammatically correct writing for the successful dissemination of research findings. Manuscripts submitted to the journal should be written in clear and precise English to ensure that the content is accessible to an international audience. Authors whose first language is not English are strongly encouraged to seek professional English language editing services before submitting their manuscripts. This ensures that the article meets the journal’s standards for clarity, coherence, and readability. The journal provides a list of recommended editing services on its website, but authors are free to choose any reputable service they wish. Manuscripts with significant language issues may be returned to the authors for revision before they proceed to the peer-review process. Authors should also be aware that the journal may suggest or require further language editing after the peer review process to ensure that the final version of the manuscript is of the highest quality. While the journal’s editorial team will check for grammatical and typographical errors, it is the author’s responsibility to ensure that the manuscript is free from language issues. Proper English usage not only helps to convey the scientific content clearly but also enhances the credibility of the work and increases its chances of being cited and used by other researchers in the field.
6. Withdrawal Policy
The Indo-American Journal of Pharma and Bio Sciences has a clearly defined manuscript withdrawal policy to address situations in which authors wish to retract their submissions after they have been submitted, reviewed, or accepted. Authors can request to withdraw their manuscript before it enters the peer review process, in which case they must notify the editorial office as soon as possible. If a manuscript is in the peer review stage or has already been accepted, withdrawal requests will be carefully considered. However, authors must provide a valid reason for the withdrawal, such as the discovery of significant errors in the data or issues related to ethics that could affect the validity of the findings. The journal reserves the right to refuse the withdrawal if the manuscript is too far along in the publication process. In some cases, withdrawal may not be possible if the article has already been scheduled for publication or has been published. If an article is retracted after publication, the journal will issue a formal retraction notice, which will be published alongside the original article to ensure transparency and maintain the integrity of the scientific record. The Indo-American Journal of Pharma and Bio Sciences is committed to handling withdrawal and retraction requests in an ethical and transparent manner, consistent with international publishing standards. Authors are encouraged to carefully review their manuscripts before submission to minimize the need for withdrawal.
7. Human and Animal Rights Policy
The Indo-American Journal of Pharma and Bio Sciences upholds the highest ethical standards in research involving human participants and animals. All research studies that involve human participants must comply with the principles outlined in the Declaration of Helsinki and must have approval from an institutional ethics review board or an equivalent ethics committee. Authors must provide a statement in the manuscript confirming that ethical approval was obtained before the study began. The journal requires that informed consent was obtained from all human participants involved in the study, and that the participants' confidentiality and privacy were protected throughout the research process. For studies involving animals, authors must adhere to internationally recognized guidelines for animal welfare, such as the Guide for the Care and Use of Laboratory Animals. Any research involving animals must have been approved by an institutional animal care and use committee (IACUC) or an equivalent body. The journal expects authors to describe the methods used to ensure humane treatment of animals in the manuscript. The Indo-American Journal of Pharma and Bio Sciences takes these ethical guidelines seriously to maintain the integrity of the research it publishes. Any failure to adhere to these standards will result in the rejection of the manuscript, and the journal may report the incident to the appropriate ethics bodies. The journal is committed to ensuring that all research published respects the rights and welfare of participants and animals involved.
8. Errata, Retractions, and Corrigenda Policy
The Indo-American Journal of Pharma and Bio Sciences is committed to the accuracy and integrity of the published scientific record. In the event that an error is identified in a published article, whether before or after publication, the journal will take appropriate steps to correct it. Minor errors, such as typographical mistakes or small inaccuracies, will be addressed by publishing a corrigendum, which provides a correction alongside the original article. If a significant error, such as a misinterpretation of data, is identified that impacts the conclusions of the study, a more formal retraction may be issued. The journal follows ethical guidelines established by the Committee on Publication Ethics (COPE) to handle retractions and corrections with transparency. In cases where research is found to involve misconduct, such as data fabrication, plagiarism, or unethical research practices, the journal reserves the right to retract the paper and issue a public statement explaining the retraction. The retraction notice will be clearly linked to the original article, and the reason for the retraction will be made public. This ensures that readers and the scientific community are aware of any changes to the published record. Authors are required to notify the editorial office immediately if they identify errors in their own work after publication. The Indo-American Journal of Pharma and Bio Sciences takes these measures seriously to maintain trust in the scientific publishing process and to uphold the highest standards of academic integrity.
9. Digital Preservation
The Indo-American Journal of Pharma and Bio Sciences employs a robust digital preservation strategy to ensure the long-term availability of its published content. The journal archives its articles in trusted digital repositories to safeguard against data loss and to ensure that research is accessible for future generations. This process is vital for maintaining the academic integrity of the journal and for ensuring that scientific findings remain accessible even in the event of technological changes or disruptions. The journal partners with global initiatives like CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) and Portico to store copies of the published content in multiple locations worldwide, providing a safeguard for long-term access. All published articles are also deposited in relevant institutional repositories where possible. Additionally, the journal’s website is designed to maintain the articles in a stable, searchable format to facilitate future reference. Authors are encouraged to ensure that all data supporting their findings is deposited in public repositories as part of their submission process. By adhering to these digital preservation practices, the Indo-American Journal of Pharma and Bio Sciences aims to enhance the longevity and accessibility of research articles, allowing the global scientific community to benefit from the knowledge contained within them for years to come.
10. APC Waiver Policy
The Indo-American Journal of Pharma and Bio Sciences recognizes that publication fees can be a barrier to authors, particularly those from low-income countries or those facing financial hardship. To ensure that quality research is not hindered by financial constraints, the journal offers an Article Processing Charge (APC) waiver policy for authors in need. This policy aims to support researchers who lack the necessary funding to cover the APC, while still ensuring that their valuable research reaches a global audience through the journal’s open-access platform. Authors who wish to request an APC waiver must submit a formal request at the time of manuscript submission, explaining their financial situation and justifying the need for support. The journal reviews each request on a case-by-case basis and will make decisions based on the author’s financial status and institutional or funding support. The APC waiver policy ensures inclusivity in scholarly publishing and aims to provide equitable opportunities for researchers worldwide, regardless of their economic background. Authors should note that the waiver only applies to the APC and does not affect the peer-review or editorial process. If granted, the waiver ensures that the manuscript is processed and published without any charges for the authors. The journal also encourages authors from institutions with APC funding programs to apply for institutional support where possible. This policy reflects the journal's commitment to facilitating the global exchange of pharmaceutical and biosciences research.
11. Participant/Patient Privacy and Informed Consent
The Indo-American Journal of Pharma and Bio Sciences prioritizes the ethical conduct of research involving human participants and patients, particularly in ensuring privacy and obtaining informed consent. The journal requires that all authors submitting research involving human subjects adhere to ethical standards for the protection of participant rights and confidentiality. Manuscripts involving human participants must include a statement confirming that the study was approved by an institutional review board (IRB) or ethics committee, and that informed consent was obtained from all participants before participation in the study. This consent must be documented and should cover the specific details of the study, including potential risks and benefits, the use of personal data, and the voluntary nature of participation. If the study involved sensitive personal data, authors must ensure that the privacy of participants is fully protected, and that all identifying information is either anonymized or removed. The Indo-American Journal of Pharma and Bio Sciences adheres to the standards set by the Declaration of Helsinki and relevant national and international guidelines to ensure the ethical treatment of human subjects. In the case of clinical trials, authors must provide registration details of the trial with a publicly accessible registry. The journal is committed to promoting research that not only contributes to scientific advancement but also respects the dignity, rights, and well-being of all individuals involved in the research process.
12. Submission of Manuscript
The Indo-American Journal of Pharma and Bio Sciences accepts manuscripts on a rolling basis for publication. Authors must submit their work electronically through the journal’s online submission system, ensuring that all required components are included. Submissions must be original and not under consideration elsewhere, and authors should confirm that all co-authors have approved the final version of the manuscript. The journal encourages authors to ensure that their manuscript adheres to the submission guidelines regarding formatting, referencing style, and structure. A typical manuscript should include a title page, abstract, keywords, introduction, methods, results, discussion, conclusion, and references. Additionally, authors must provide a cover letter explaining the significance of the study and how it contributes to the field of pharmaceutical and biosciences research. The manuscript should also include statements about ethical approval for human or animal research, conflicts of interest, and any funding sources. Submissions that do not comply with the journal’s guidelines may be returned to the author for revisions before being considered for review. Once submitted, manuscripts undergo a preliminary check to ensure they meet the journal’s scope and standards. If deemed suitable, they are sent out for peer review. Authors will be notified about the status of their submission within a reasonable timeframe, and upon acceptance, they will be informed about the Article Processing Charge (APC) and publication timeline.
13. Manuscript Preparation
The Indo-American Journal of Pharma and Bio Sciences has clear guidelines for manuscript preparation to ensure consistency, readability, and compliance with academic standards. Manuscripts should be written in standard English, following the specific formatting and referencing requirements outlined by the journal. The title page should include the title of the article, the names of all authors, their affiliations, and corresponding author details. The abstract should be concise (150-250 words), summarizing the key objectives, methods, results, and conclusions of the study. Authors should provide 3-5 keywords that accurately describe the content of the manuscript. The main body of the manuscript should be structured into sections, including Introduction, Methods, Results, Discussion, and Conclusion. Each section should be clearly marked and logically organized to enhance readability. Tables, figures, and supplementary materials should be formatted according to the journal's specifications and included at the end of the manuscript or uploaded separately. The references should be cited in the appropriate format, typically using the APA or Vancouver style, and should only include sources that are relevant and current. All submitted manuscripts will be checked for plagiarism using advanced detection tools. Authors should ensure that their manuscript is original and free from any plagiarism. In addition, authors should provide statements of ethical approval for studies involving human or animal subjects, conflict of interest disclosures, and funding acknowledgments. These guidelines help maintain high standards of quality and consistency across the journal’s publications.
20. Open Access Policy
The Indo-American Journal of Pharma and Bio Sciences follows a strict open access policy, meaning that all research articles published are made freely available to the public, without any subscription or paywall. This ensures that the knowledge disseminated through the journal is accessible to researchers, healthcare professionals, policy-makers, and the general public worldwide. By adhering to this policy, the journal promotes the free exchange of scientific and academic information, facilitating collaborations, innovations, and discussions within the global scientific community. Authors retain the copyright to their work under the Creative Commons Attribution License (CC BY), which allows anyone to share, remix, or adapt the work for any purpose, provided the original author is properly credited. This open-access model enhances the visibility of authors’ work and increases the impact of research findings, making it easier for others to cite and build upon them. The journal ensures compliance with all relevant open-access regulations and guidelines, providing a platform for high-quality research across a broad range of pharmaceutical and biomedical topics. Open access also benefits authors from institutions with limited subscription budgets, as their work can reach a larger and more diverse audience, which is vital for advancing research and practice in the field. Authors are informed of the open access model and the licensing options available when submitting their manuscripts.
